|
FDA Approval Activities for this Drug
OptiMark (gadoversetamide) Injection, Tyco/Mallinckrodt Health Care NDA 20-937/S3
NDA 20-975/S3
NDA 20-976/S3 1/31/03 2/12/03 2/13/03
OptiMark (gadoversetamide) Injection Mallinckrodt, NDA 20-937
NDA 20-975
NDA 20-976
For the most up-to-date approval information, please locate this API using the drug index.
|